Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.93USD
21 Sep 2018
Change (% chg)

$-0.05 (-1.26%)
Prev Close
$3.98
Open
$3.98
Day's High
$3.98
Day's Low
$3.92
Volume
5,942
Avg. Vol
23,193
52-wk High
$5.34
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 0.75 1.50 0.00 --
Quarter Ending Dec-18 2 0.75 1.50 0.00 --
Year Ending Dec-18 2 1.50 3.00 0.00 0.00
Year Ending Dec-19 2 3.00 6.00 0.00 0.00
Earnings (per share)
Quarter Ending Sep-18 2 -0.09 -0.03 -0.16 -0.27
Quarter Ending Dec-18 2 -0.10 -0.04 -0.16 -0.31
Year Ending Dec-18 2 -0.47 -0.35 -0.60 -1.18
Year Ending Dec-19 2 -0.43 -0.10 -0.76 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 1.54 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) 10.34 15.51 5.00
Price to Tangible Book (MRQ) 10.39 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 12.71 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 16.50 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 10.80 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.27 12.51
Total Debt to Equity (MRQ) 0.00 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,229,030 860,305,024
Net Income/Employee (TTM) -- 3,144,146 101,198,978
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 -0.15 11.13
Return on Assets - 5 Yr. Avg. -71.19 3.51 12.40
Return on Investment (TTM) -52.76 1.79 14.61
Return on Investment - 5 Yr. Avg. -91.15 2.56 16.13
Return on Equity (TTM) -52.76 3.28 16.33
Return on Equity - 5 Yr. Avg. -93.46 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.91%
# of Holders: 45
Total Shares Held: 2,462,063
3 Mo. Net Change: 779,245
# New Positions: 10
# Closed Positions: 5
# Increased Positions: 25
# Reduced Positions: 7
# Net Buyers: 18
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.